Ya‐Bin Qi

Type I and type II <i>Helicobacter pylori</i> infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area

Lin Yuan, Junbo Zhao, Yinglei Zhou et al. · World Journal of Gastroenterology · 2020 · 40 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Rabeprazole plus amoxicillin dual therapy is equally effective to bismuth‐containing quadruple therapy for <i>Helicobacter pylori</i> eradication in central China: A single‐center, prospective, open‐label, randomized‐controlled trial

Qiao‐Qiao Shao, Xue‐Chun Yu, Miao Yu et al. · Helicobacter · 2022 · 25 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Both family‐based <i>Helicobacter pylori</i> infection control and management strategy and screen‐and‐treat strategy are cost‐effective for gastric cancer prevention

Jing Ma, Miao Yu, Qiao‐Qiao Shao et al. · Helicobacter · 2022 · 23 citations

Pharmacy, Pharmacoeconomics, Preventive Medicine +17

LncRNA 1700020I14Rik promotes AKR1B10 expression and activates Erk pathway to induce hepatocyte damage in alcoholic hepatitis

Yue Wu, Ya‐Bin Qi, Yangqiu Bai et al. · Cell Death Discovery · 2022 · 18 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Gastric mucosal precancerous lesions in <i>Helicobacter pylori</i>-infected pediatric patients in central China: A single-center, retrospective investigation

Miao Yu, Jing Ma, Xiaoxia Song et al. · World Journal of Gastroenterology · 2022 · 13 citations · Full text

Medicine, Pathology, Pediatrics +17